CTOs on the Move

Stimwave Technologies

www.stimwavefreedom.com

 
Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Stimwave Technologies raised $50M on 01/12/2018

Similar Companies

Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.

Bio Cybernetics International

Bio Cybernetics International is a La Verne, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lemonaid Health

Lemonaid Health is leading a second wave of telehealth where technology algorithms power quality care. Lemonaid leverages evidence-based guidelines and the most up-to-date clinical protocols to offer a service direct to consumer for less than typical co-pays.

Cardiac Insight

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA. Cardiac Insight is developing advanced, body worn ECG sensing technology aimed at the early diagnosis of atrial fibrillation (AF) and other conditions. Earlier last year, the company announced a strategic collaboration with Welch Allyn, now part of the Hill-Rom family of companies, for the distribution rights of certain products and technologies offered by Cardiac Insight.

Sirtex

Sirtex is a rapidly growing, profitable, global life-sciences business focused on helping medical professionals improve clinical outcomes for cancer patients through innovative and effective interventional oncology therapies.